CD274 and neoplasm: In addition to these effects, anti-PD-1 and anti-PD-L1 therapies increase the levels of M1-like macrophages markers and promote macrophage polarization towards the pro-inflammatory phenotype (38–40), improve NK cell anti-tumour efficacy and promote NK cell persistence and retention of their cytotoxic phenotype (41, 42).